Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
First Bancorp
FNLC
$405M
| $310K | ﹤0.01% |
10,504
-8,129
| -44% | -$243K |
|
3302
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$273M
| $310K | ﹤0.01% |
+11,241
| New | +$320K |
|
3303
United Fire Group
UFCS
$1.4B
| $310K | ﹤0.01% |
11,201
-15,203
| -58% | -$473K |
|
3304
Blue Bird Corp
BLBD
$2.45B
| $309K | ﹤0.01% |
12,473
-16,666
| -57% | -$438K |
|
3305
NextCure
NXTC
$23.2M
| $309K | ﹤0.01% |
3,205
+32
| +1% | +$3.27K |
|
|
UBA
3306
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $309K | ﹤0.01% |
15,962
-23,910
| -60% | -$442K |
|
3307
DXP Enterprises
DXPE
$2.65B
| $307K | ﹤0.01% |
9,201
-13,069
| -59% | -$403K |
|
|
EVRI
3308
DELISTED
Everi Holdings
EVRI
| $307K | ﹤0.01% |
12,307
-67,754
| -85% | -$1.28M |
|
|
KYNB
3309
Kyntra Bio
KYNB
$28.3M
| $306K | ﹤0.01% |
459
-3,436
| -88% | -$1.98M |
|
|
CCRN
3310
DELISTED
Cross Country Healthcare
CCRN
| $304K | ﹤0.01% |
18,426
-25,858
| -58% | -$395K |
|
3311
iShares MSCI Thailand ETF
THD
$370M
| $304K | ﹤0.01% |
+3,901
| New | +$313K |
|
3312
Globalstar
GSAT
$10.8B
| $302K | ﹤0.01% |
11,322
+5,744
| +103% | +$113K |
|
3313
Seaboard Corp
SEB
$4.15B
| $302K | ﹤0.01% |
78
+28
| +56% | +$105K |
|
3314
PUT
McDonald's
MCD
$190B
| $300K | ﹤0.01% |
1,300
-1,100
| -46% | -$256K |
|
3315
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$340M
| $299K | ﹤0.01% |
2,700
-6,000
| -69% | -$677K |
|
3316
SI-BONE Inc
SIBN
$820M
| $298K | ﹤0.01% |
9,471
-14,679
| -61% | -$475K |
|
3317
Vera Bradley
VRA
$99.8M
| $297K | ﹤0.01% |
23,971
-17,422
| -42% | -$199K |
|
|
CODX
3318
Co-Diagnostics
CODX
$5.79M
| $296K | ﹤0.01% |
1,196
-258
| -18% | -$66.3K |
|
3319
Funko
FNKO
$319M
| $295K | ﹤0.01% |
13,959
-6,552
| -32% | -$149K |
|
3320
Mitek Systems
MITK
$807M
| $295K | ﹤0.01% |
15,281
-54,299
| -78% | -$914K |
|
3321
Verastem
VSTM
$511M
| $295K | ﹤0.01% |
6,033
-5,936
| -50% | -$247K |
|
|
SLCT
3322
DELISTED
Select Bancorp, Inc.
SLCT
| $295K | ﹤0.01% |
18,307
-49,893
| -73% | -$689K |
|
3323
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
| $294K | ﹤0.01% |
+2,985
| New | +$286K |
|
3324
Esquire Financial Holdings
ESQ
$1.11B
| $294K | ﹤0.01% |
12,415
-4,877
| -28% | -$116K |
|
|
HTT
3325
High Templar Tech Ltd
HTT
$390M
| $293K | ﹤0.01% |
121,816
+18,961
| +18% | +$40.6K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.